Compare Triumeq vs. Genvoya
Head-to-head comparisons of medication uses, side effects, ratings, and more.
Treats HIV infections.
Triumeq (abacavir / dolutegravir / lamivudine) is a 3-in-1 tablet and is one of the first choices used in treating HIV infections. Your doctor will test you to see if you're at risk for developing an allergic reaction to Triumeq (abacavir / dolutegravir / lamivudine) before prescribing it.
Treats HIV infection.
Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) is a convenient 4-in-1 medication. It's one of the first choices used to treat HIV infections and contains a newer medication that's safer for your kidneys and bones.
Upsides
- One of the first choice medications used to treat HIV.
- Can take once daily and with or without food.
- Triumeq (abacavir / dolutegravir / lamivudine) contains three different HIV drugs in one tablet.
- First-choice treatment for HIV infections.
- One tablet contains four different HIV medications and is only taken once daily.
- Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) has fewer side effects (headache, nausea, fatigue, diarrhea), and is safer on your kidneys and bones than Stribild.
Downsides
- Can increase your risk of heart attack, especially if you have high blood pressure, high cholestorol, diabetes, or if you smoke.
- Triumeq (abacavir / dolutegravir / lamivudine) is not recommended if you have liver problems or poor kidney health.
- Some people have had severe allergic reactions while taking Triumeq (abacavir / dolutegravir / lamivudine). Your doctor will test you for any possible risk of reaction before starting.
- Should be taken with food.
- Can increase cholesterol levels.
- Can interact with many other drugs.
Used for
Dosage forms
- Pill
- Pill
Price
Lowest price
$3323.38
Find instant savings near youLowest price
$3566.41
Find instant savings near youWant to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
Risks and risk factors
- Severe allergic reaction
- Previous allergic reaction to Triumeq or abacavir
- Presence of HLA-B*5701 gene
- Lactic acidosis | Enlarged, fatty liver
- Liver disease
- Women
- Obesity
- Worsening of hepatitis B or C
- Hepatitis B infection
- Hepatitis C infection
- Fat redistribution
- HIV treatment
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Heart attack
- History of coronary heart disease
- High blood pressure
- Dyslipidemia
- Diabetes mellitus
- Smoking
- Lactic acidosis | Enlarged, fatty liver
- Liver disease
- Women
- Obesity
- Worsening hepatitis B infection
- Hepatitis B Virus infection
- Kidney damage
- History of kidney damage
- Taking other medicines that can harm the kidneys
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Drug interactions
- Taking medicines that interact with Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir)